Noffsinger A E, Suzuk L, Hui Y Z, Gal A A, Fenoglio-Preiser C M
Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Ohio, USA.
Mod Pathol. 1995 Jun;8(5):509-14.
Anogenital malignancy has been increasing in incidence in recent decades. There is strong evidence in the literature suggesting that human papillomavirus (HPV) plays a role in the genesis of anogenital neoplasia. In addition, identification of oncogenic HPV types in anogenital carcinomas may have prognostic significance. The method used to detect HPV infection, however, affects the frequency with which viral DNA is identified. We examined tissues from 56 patients with anal squamous cell carcinoma for the presence of HPV DNA by in situ hybridization and polymerase chain reaction using both consensus and type-specific primers to determine if HPV detection varies when different methods are used. In situ hybridization identified the presence of HPV DNA in 41.1% of patients. Polymerase chain reaction using type-specific probes for the HPV E6 gene demonstrated HPV DNA in 46% of anal carcinomas, whereas polymerase chain reaction with consensus primers detected HPV DNA in only 16.3% of cases. All cases containing HPV type 6 were identified with L1 primers, whereas only three of 23 cases containing HPV type 16 were identified. The differences in the rate of HPV detection by the two polymerase chain reactions methods are most likely related to L1 gene loss in cells containing integrated HPV type 16.
近几十年来,肛门生殖器恶性肿瘤的发病率一直在上升。文献中有强有力的证据表明,人乳头瘤病毒(HPV)在肛门生殖器肿瘤的发生中起作用。此外,在肛门生殖器癌中鉴定致癌HPV类型可能具有预后意义。然而,用于检测HPV感染的方法会影响病毒DNA的识别频率。我们通过原位杂交和聚合酶链反应,使用通用引物和型特异性引物,检测了56例肛门鳞状细胞癌患者组织中HPV DNA的存在情况,以确定使用不同方法时HPV检测结果是否存在差异。原位杂交显示41.1%的患者存在HPV DNA。使用HPV E6基因的型特异性探针进行聚合酶链反应,在46%的肛门癌中检测到HPV DNA,而使用通用引物的聚合酶链反应仅在16.3%的病例中检测到HPV DNA。所有含有6型HPV的病例均通过L1引物鉴定出来,而在23例含有16型HPV的病例中,仅鉴定出3例。两种聚合酶链反应方法检测HPV的率差异很可能与含有整合型16型HPV的细胞中L1基因缺失有关。